Literature DB >> 912585

Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.

M Peacock, P J Heyburn, J E Aaron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 912585     DOI： 10.1007/bf02064041

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN： 0008-0594


× No keyword cloud information.
  6 in total

1.  The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.

Authors:  R G Russell; R Smith; C Preston; R J Walton; C G Woods; R G Henderson; A W Norman
Journal:  Clin Sci Mol Med       Date:  1975-03

2.  The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels.

Authors:  M R Haussler; D J Baylink; M R Hughes; P F Brumbaugh; J E Wergedal; F H Shen; R L Nielsen; S J Counts; K M Bursac; T A McCain
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

Review 3.  Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes.

Authors:  C R Scriver
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

4.  Hypophosphataemic osteomalacia presenting in adults.

Authors:  C E Dent; T C Stamp
Journal:  Q J Med       Date:  1971-04

5.  Evidence for a phosphorus-depletion syndrome in man.

Authors:  M Lotz; E Zisman; F C Bartter
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

6.  Iatrogenic osteomalacia and myopathy due to phosphate depletion.

Authors:  L R Baker; P Ackrill; W R Cattell; T C Stamp; L Watson
Journal:  Br Med J       Date:  1974-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.